Annual Total Long Term Liabilities
$113.97 M
+$79.09 M+226.73%
31 December 2023
Summary:
Armata Pharmaceuticals annual total long term liabilities is currently $113.97 million, with the most recent change of +$79.09 million (+226.73%) on 31 December 2023. During the last 3 years, it has risen by +$100.01 million (+716.73%). ARMP annual total long term liabilities is now at all-time high.ARMP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$31.01 M
-$227.00 K-0.73%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly total long term liabilities is currently $31.01 million, with the most recent change of -$227.00 thousand (-0.73%) on 30 September 2024. Over the past year, it has dropped by -$72.26 million (-69.97%). ARMP quarterly long term liabilities is now -72.79% below its all-time high of $113.97 million, reached on 31 December 2023.ARMP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +226.7% | -70.0% |
| 3 y3 years | +716.7% | +127.0% |
| 5 y5 years | +10000.0% | +399.5% |
ARMP Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +716.7% | -72.8% | +127.0% |
| 5 y | 5 years | at high | >+9999.0% | -72.8% | +627.3% |
| alltime | all time | at high | >+9999.0% | -72.8% |
Armata Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $31.01 M(-0.7%) |
| June 2024 | - | $31.23 M(-53.3%) |
| Mar 2024 | - | $66.82 M(-41.4%) |
| Dec 2023 | $113.97 M(+226.7%) | $113.97 M(+10.4%) |
| Sept 2023 | - | $103.26 M(+238.5%) |
| June 2023 | - | $30.51 M(-12.6%) |
| Mar 2023 | - | $34.92 M(+0.1%) |
| Dec 2022 | $34.88 M(-11.8%) | $34.88 M(-13.4%) |
| Sept 2022 | - | $40.30 M(-0.0%) |
| June 2022 | - | $40.31 M(+0.8%) |
| Mar 2022 | - | $40.00 M(+1.1%) |
| Dec 2021 | $39.56 M(+183.5%) | $39.56 M(+189.5%) |
| Sept 2021 | - | $13.66 M(-0.7%) |
| June 2021 | - | $13.76 M(-0.7%) |
| Mar 2021 | - | $13.85 M(-0.7%) |
| Dec 2020 | $13.95 M(+133.4%) | $13.95 M(-0.2%) |
| Sept 2020 | - | $13.99 M(-4.3%) |
| June 2020 | - | $14.62 M(+242.9%) |
| Mar 2020 | - | $4.26 M(-28.7%) |
| Dec 2019 | $5.98 M(+610.9%) | $5.98 M(-3.7%) |
| Sept 2019 | - | $6.21 M(-6.7%) |
| June 2019 | - | $6.65 M(+524.6%) |
| Mar 2019 | - | $1.06 M(+26.6%) |
| Dec 2018 | $841.00 K(-41.6%) | $841.00 K(-35.4%) |
| Sept 2018 | - | $1.30 M(-2.3%) |
| June 2018 | - | $1.33 M(-0.1%) |
| Mar 2018 | - | $1.33 M(-7.3%) |
| Dec 2017 | $1.44 M(-70.6%) | $1.44 M(-7.0%) |
| Sept 2017 | - | $1.55 M(+0.8%) |
| June 2017 | - | $1.53 M(-67.9%) |
| Mar 2017 | - | $4.78 M(-2.3%) |
| Dec 2016 | $4.89 M(-70.2%) | $4.89 M(+5.1%) |
| Sept 2016 | - | $4.65 M(+4.1%) |
| June 2016 | - | $4.47 M(-73.2%) |
| Mar 2016 | - | $16.71 M(+1.9%) |
| Dec 2015 | $16.39 M(-29.7%) | $16.39 M(+1.5%) |
| Sept 2015 | - | $16.16 M(-23.5%) |
| June 2015 | - | $21.12 M(-46.6%) |
| Mar 2015 | - | $39.56 M(+69.7%) |
| Dec 2014 | $23.31 M(-62.1%) | $23.31 M(+59.9%) |
| Sept 2014 | - | $14.58 M(-62.5%) |
| June 2014 | - | $38.92 M(-32.4%) |
| Mar 2014 | - | $57.58 M(-6.3%) |
| Dec 2013 | $61.45 M(+1896.3%) | $61.45 M(>+9900.0%) |
| Dec 2012 | $3.08 M(-55.6%) | - |
| Sept 2009 | - | $0.00(-100.0%) |
| June 2009 | - | $91.00 K(-98.7%) |
| Mar 2009 | - | $6.77 M(-2.5%) |
| Dec 2008 | $6.94 M(-8.5%) | $6.94 M(-2.4%) |
| Sept 2008 | - | $7.10 M(-2.2%) |
| June 2008 | - | $7.26 M(-2.1%) |
| Mar 2008 | - | $7.42 M(-2.0%) |
| Dec 2007 | $7.58 M | $7.58 M(+37.4%) |
| Sept 2007 | - | $5.51 M(-22.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2007 | - | $7.10 M(+19.0%) |
| Mar 2007 | - | $5.96 M(-13.7%) |
| Dec 2006 | $6.91 M(-49.2%) | $6.91 M(-41.9%) |
| Sept 2006 | - | $11.89 M(-18.6%) |
| June 2006 | - | $14.60 M(-4.3%) |
| Mar 2006 | - | $15.26 M(+12.2%) |
| Dec 2005 | $13.60 M(-16.1%) | $13.60 M(-6.6%) |
| Sept 2005 | - | $14.56 M(-8.9%) |
| June 2005 | - | $15.99 M(-1.7%) |
| Mar 2005 | - | $16.27 M(+0.4%) |
| Dec 2004 | $16.21 M(-3.1%) | $16.21 M(-2.0%) |
| Sept 2004 | - | $16.53 M(+1.9%) |
| June 2004 | - | $16.23 M(-1.4%) |
| Mar 2004 | - | $16.46 M(-1.7%) |
| Dec 2003 | $16.73 M(-51.9%) | $16.73 M(+11.4%) |
| Sept 2003 | - | $15.02 M(-37.6%) |
| June 2003 | - | $24.09 M(-30.4%) |
| Mar 2003 | - | $34.61 M(-0.5%) |
| Dec 2002 | $34.78 M(+2.2%) | $34.78 M(-1.6%) |
| Sept 2002 | - | $35.34 M(-6.1%) |
| June 2002 | - | $37.64 M(+77.0%) |
| Mar 2002 | - | $21.26 M(-37.5%) |
| Dec 2001 | $34.02 M(+187.0%) | $34.02 M(+91.7%) |
| Sept 2001 | - | $17.75 M(+76.4%) |
| June 2001 | - | $10.06 M(+4.4%) |
| Mar 2001 | - | $9.64 M(-18.7%) |
| Dec 2000 | $11.86 M(+464.6%) | $11.86 M(+125.2%) |
| Sept 2000 | - | $5.27 M(+126.9%) |
| June 2000 | - | $2.32 M(+8.1%) |
| Mar 2000 | - | $2.15 M(+2.2%) |
| Dec 1999 | $2.10 M(+133.3%) | $2.10 M(+90.9%) |
| Sept 1999 | - | $1.10 M(-8.3%) |
| June 1999 | - | $1.20 M(+20.0%) |
| Mar 1999 | - | $1.00 M(+11.1%) |
| Dec 1998 | $900.00 K(-40.0%) | $900.00 K(-30.8%) |
| Sept 1998 | - | $1.30 M(-13.3%) |
| June 1998 | - | $1.50 M(-11.8%) |
| Mar 1998 | - | $1.70 M(+13.3%) |
| Dec 1997 | $1.50 M(-28.6%) | $1.50 M(-16.7%) |
| Sept 1997 | - | $1.80 M(-10.0%) |
| June 1997 | - | $2.00 M(+5.3%) |
| Mar 1997 | - | $1.90 M(-9.5%) |
| Dec 1996 | $2.10 M(-12.5%) | $2.10 M(-4.5%) |
| Sept 1996 | - | $2.20 M(-8.3%) |
| June 1996 | - | $2.40 M(-11.1%) |
| Mar 1996 | - | $2.70 M(+12.5%) |
| Dec 1995 | $2.40 M(+9.1%) | $2.40 M(+20.0%) |
| Sept 1995 | - | $2.00 M(-9.1%) |
| June 1995 | - | $2.20 M(-8.3%) |
| Mar 1995 | - | $2.40 M(+9.1%) |
| Dec 1994 | $2.20 M(+120.0%) | $2.20 M(+22.2%) |
| Sept 1994 | - | $1.80 M(0.0%) |
| June 1994 | - | $1.80 M(+80.0%) |
| Dec 1993 | $1.00 M | $1.00 M |
FAQ
- What is Armata Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Armata Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Armata Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of ARMP is $113.97 M
What is the all time high annual total long term liabilities for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual total long term liabilities is $113.97 M
What is Armata Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, ARMP annual total long term liabilities has changed by +$79.09 M (+226.73%)
What is Armata Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ARMP is $31.01 M
What is the all time high quarterly long term liabilities for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly total long term liabilities is $113.97 M
What is Armata Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ARMP quarterly total long term liabilities has changed by -$72.26 M (-69.97%)